Show Summary Details
Page of

Pulmonary amyloidosis 

Pulmonary amyloidosis
Pulmonary amyloidosis

D.J. Hendrick


July 30, 2015: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 September 2021

Amyloidosis rarely affects the lungs, but when it does, primary (AL) disease usually produces benign masses of amyloid tissue in the central airways or the parenchyma, and secondary (AA) disease typically causes diffuse infiltration of alveolar walls and interstitium. Laryngotracheobronchial deposits sometimes require resection if they are causing obstruction; parenchymal lung nodules rarely need to be removed, providing their histological nature is not in doubt; the prognosis of diffuse alveolar–interstitial disease is poor....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.